Microbot Medical Inc. Files 8-K with Financial Exhibits
Ticker: MBOT · Form: 8-K · Filed: Jul 3, 2024 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Jul 3, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
TL;DR
Microbot Medical filed an 8-K with financial exhibits, check for updates.
AI Summary
On July 3, 2024, Microbot Medical Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating potential updates or disclosures related to the company's financial health and operations. No specific dollar amounts or new material events were detailed in the provided excerpt.
Why It Matters
This filing provides an update on Microbot Medical Inc.'s financial statements and exhibits, which could contain important information for investors regarding the company's financial performance and operational status.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, with no immediate indication of significant new risks or material adverse events.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Braintree, MA (location) — Principal Executive Offices
FAQ
What specific financial statements or exhibits are being filed with this 8-K?
The provided excerpt states that the filing includes 'Financial Statements and Exhibits' but does not list the specific documents.
Does this 8-K report any new material events or updates beyond financial disclosures?
The filing lists 'Regulation FD Disclosure' and 'Other Events' as item information, but the excerpt does not detail any specific events.
What is the principal executive office address for Microbot Medical Inc.?
The principal executive offices are located at 288 Grove Street, Suite 388, Braintree, MA 02184.
When was the earliest event reported in this 8-K filing?
The date of the earliest event reported is July 3, 2024.
What is Microbot Medical Inc.'s IRS Employer Identification Number?
Microbot Medical Inc.'s IRS Employer Identification Number is 94-3078125.
Filing Stats: 786 words · 3 min read · ~3 pages · Grade level 12.3 · Accepted 2024-07-03 08:20:28
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex99-1.htm (EX-99.1) — 12KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-24-026135.txt ( ) — 235KB
- mbot-20240703.xsd (EX-101.SCH) — 3KB
- mbot-20240703_lab.xml (EX-101.LAB) — 33KB
- mbot-20240703_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01 of this Current Report on Form 8-K contains "forward-looking statements." Such statements which are not purely
Item 8.01 of this Current Report on Form 8-K contains "forward-looking statements." Such statements which are not purely historical (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "intends," "would," "could" and "estimates") are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, regulatory milestones. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this Form 8-K, and the Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Although the Company believes that the beliefs, plans, expectations and intentions contained in this Form 8-K are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the Company's reports and statements filed from time-to-time with the Securities and Exchange Commission. Item 9.01. Financial (d) Exhibits Exhibit Number Description 99.1 Press Release 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: July 3, 2024